 FSD Pharma Inc. NASDAQ:HUGE CSE:HUGE has announced the appointment of Nathan Coyle, the companys corporate controller as its interim chief financial officer with immediate effect, following the departure of Donal Carroll. The company noted that Coyle joined FSD Pharma as corporate controller in 2020 and has 15 years of executive business experience as a finance leader in both public and private roles. 